Since leucine can be metabolised to acetyl-CoA and used for energy production, the substantial reduction of BCATm in BCATmKO tumours may have negatively impacted the energy status of the tumours, causing activation of AMPKα. The gene discussed is BCAT2; the disease is neoplasm.